Sex-and Gender-Based Analysis at Work:
What it means for Women and their Health

Monday, November 30, 2009  1:30 - 4:00 PM
Ottawa Public Library (Main Branch), 120 Metcalfe (at Laurier)
RSVP by emailing info@cwhn.ca. Registration is free.

What is sex- and gender-based analysis, and why is it important?

The forum will explore sex and gender as determinants of health and the concepts of sex, gender, diversity and equity as they relate to health. Panelists from the Centres of Excellence for Women’s Health across Canada will discuss the importance of a sex-and gender-based approach with practical examples from the brand new book, Rising to the Challenge: Sex-and gender-based analysis for health planning, policy and research in Canada. This forum is important for women, those who provide their care, those who research their lives and plan policies that affect them.

Please email info@cwhn.ca by Thursday, November 26 as space is limited. Print invitation

You are also invited to a Reception and Book Launch following the workshop.

Rising to the Challenge:
Sex and gender-based analysis for health planning, policy and research in Canada.

Monday, November 30, 2009, 5-7 p.m.
Hotel Indigo Ottawa, 123 Metcalfe (at Laurier)
Refreshments and cash bar begin at 5 p.m.
RSVP by emailing info@cwhn.ca

•    Meet the book’s authors visiting from across the country.
•    Mingle with Ottawa’s community builders, policy-makers and researchers.
•    Have a look at our terrific publication!

Rising to the Challenge is a book that describes the process of sex- and gender-based analysis and offers a collection of case studies and commentaries that illustrate SGBA in action. The book is of interest to people working on policy, planning and research and to people at various levels of government. It will help readers understand sex- and gender-based analysis and learn how to apply it in their work for and with women and men, girls and boys.

Production of this book and these events has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.

The Canadian Women’s Health Network (CWHN) was created in 1993 as a voluntary national organization to improve the health and lives of girls and women in Canada and the world by collecting, producing, distributing and sharing knowledge, ideas, education, information, resources, strategies and inspirations.

We are a far-reaching web of researchers and activists, mothers, daughters, caregivers, and family members, people working in community clinics and on hospital floors, at the university, in provincial and federal health ministries, and in women’s organizations, all dedicated to bettering women’s health and equality.

The CWHN is currently revisiting its role as a Canada's independent voice for women's health. As part of this strategic planning, we hope that you would share your input as we take our next steps forward. Please respond to the survey by November 13, 2009

Click here to complete the Future of the CWHN Survey.

Meet some authors of the new book, The Push to Prescribe, for an online discussion about women and Canadian drug policy

WATCH THE WEBINAR! (recorded Wednesday Nov. 4, 2009)

Drugs are produced, regulated, marketed, and used in ways that affect many aspects of everyday life. The nature and extent of these effects, and their special meaning for women, are at the core of the The Push to Prescribe (Women’s Press, 2009). Editor Anne Rochon Ford and contributors Colleen Fuller and Abby Lippman presented key issues from the book and responded to questions from participants.

For more information on The Push to Prescribe, visit http://www.nnewh.org/article.php?itemID=49&section=1 

Watched the webinar? Please tell us what you thought!
Click here to complete the evaluation

Production of this webinar has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.

WATCH THE WEBINAR! (recorded Thursday Oct. 29, 2009)

Presenter: Dr. Barbara Mintzes, Assistant Professor, UBC Department of Pharmacology & Therapeutics, UBC Centre for Health Services & Policy Research, and Steering Committee member, Women and Health Protection

Antidepressants are increasingly being used to treat depression in pregnancy in Canada despite their lack of approval for this use by Health Canada or the US FDA. Recent scientific and public attention has focused on an increased risk for infants, and this has led to conflicting advice about the use of SSRI/SNRI antidepressants (such as Prozac, Paxil, Effexor, or other related drugs) during pregnancy. Some suggest avoiding all exposures, while others recommend use in order to avoid harm to mothers and infants from untreated depression.

Mintzes presents what she and colleagues found in a systematic evaluation of all available studies comparing women with depression who did or did not take antidepressants during pregnancy. Their goal was to find an answer to the controversial and urgent clinical question: do pregnant women benefit from taking antidepressants?

Watched the webinar? Please tell us what you thought!
Click here to complete the evaluation form

Production of this webinar has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.